Annual Drug Patent Expirations for OXBRYTA
Oxbryta is a drug marketed by Global Blood Theraps and is included in one NDA. There are seven patents protecting this drug.
This drug has one hundred and sixty-eight patent family members in thirty-two countries.
The generic ingredient in OXBRYTA is voxelotor. Additional details are available on the voxelotor profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
